simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 11;5^{th}-Individual ID 11;5^{th}-Individual ID 11;5^{th}-Individual ID 11;5^{th}-Individual ID 11;;;95^{th}-Individual ID 7;95^{th}-Individual ID 7;95^{th}-Individual ID 7;95^{th}-Individual ID 7;95^{th}-Individual ID 7
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.160309941194623;-0.12606022590964;-0.0526882645991286;-0.0445904582052097;-0.100823592806656;;;0.702510792693931;-0.207058701543123;0.0878588430069709;0.251772974502223;0.0528884939867345
;-0.166507400805354;-0.147015661279003;-0.0557362769257454;-0.0505433944787457;-0.108368305393783;;;0.651097711605003;-0.208804800441662;0.0839503965554344;0.242310945368932;0.0520185333903669
;-0.154112481583892;-0.105104790540277;-0.0496402522725118;-0.0386375219316737;-0.0932788802195296;;;0.753923873782858;-0.205312602644585;0.0917672894585075;0.261235003635514;0.0537584545831022
;0.999557499905624;0.991881123701612;0.999009682549961;0.994748408526463;0.998344076033144;;;0.998416012014913;0.999978936009942;0.999414156043351;0.999581815653747;0.99991986153061
;3.9510868655648e-06;0.000311238901066735;1.32306014597637e-05;0.000161774801998178;2.86131279757385e-05;;;2.67684478623301e-05;4.1030099486133e-08;6.01919123130903e-06;3.62990296217825e-06;3.04481471885376e-07
